...
首页> 外文期刊>International ophthalmology >Repeatability of primary selective laser trabeculoplasty in patients with primary open-angle glaucoma.
【24h】

Repeatability of primary selective laser trabeculoplasty in patients with primary open-angle glaucoma.

机译:原发性开角型青光眼患者原发性选择性激光小梁成形术的可重复性。

获取原文
获取原文并翻译 | 示例
           

摘要

To determine if primary selective laser trabeculoplasty (SLT) can be repeated with clinical benefit in patients with primary open-angle glaucoma (POAG). Forty-two eyes of 42 patients with POAG were studied. All patients underwent primary SLT treatment of 40-50 shots to the trabecular meshwork over 360°. The treatment response at the initial post-SLT visit (4?weeks), and second post-SLT visit (mean 4?months), clinical success and duration of clinical success were measured. SLT was repeated in all patients after failure to maintain target intraocular pressure (IOP). The same parameters were measured after repeat SLT. The main outcome measures were success of treatment (as defined by reduction of IOP by at least 20?% and below an individually determined target pressure), duration of treatment success and reduction in IOP. No significant difference between initial and repeat treatments was found for mean reduction in IOP or success rate, or duration of success. Survival analysis found significantly longer benefit for repeat treatment compared to initial treatment (P?
机译:为了确定是否可以在原发性开角型青光眼(POAG)患者中重复进行原发性选择性激光小梁成形术(SLT),并具有临床益处。研究42例POAG患者的42只眼。所有患者均在360°范围内接受了40至50次小梁网的SLT初次治疗。在首次SLT访视后(4周)和第二次SLT访视(平均4个月)时,测量治疗反应,临床成功和临床成功持续时间。所有患者均未能维持目标眼压(IOP)后再次进行SLT。重复SLT后测量相同的参数。主要的预后指标是治疗是否成功(定义为眼压降低至少20%,且低于单独确定的目标压力),治疗成功的持续时间和眼压降低。未发现初始治疗和重复治疗之间的平均眼压降低或成功率或成功持续时间有显着差异。生存分析发现,与初始治疗相比,重复治疗的获益明显更长(P <0.01)。在降低IOP和成功率方面,在POAG眼中重复进行SLT治疗与初次SLT治疗具有相似的疗效,可延长治疗成功的时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号